Back to top
more

The Ensign Group (ENSG)

(Delayed Data from NSDQ)

$141.37 USD

141.37
312,093

+1.19 (0.85%)

Updated Aug 15, 2024 04:00 PM ET

After-Market: $142.17 +0.80 (0.57%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 251)

Industry: Medical - Nursing Homes

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Should iShares Core S&P Small-Cap ETF (IJR) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for IJR

Should iShares S&P SmallCap 600 Growth ETF (IJT) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for IJT

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Zacks Equity Research

Sector ETF report for PSCH

Ensign Group (ENSG) Rises 30% in 6 Months: More Room to Run?

by Zacks Equity Research

Ensign Group (ENSG) is well-poised for improvement on growing revenues derived from catering to patients under Medicaid and Medicare programs. Solid cash flows are other tailwinds.

Ritujay Ghosh headshot

4 Stocks to Watch on Dividend Hikes Before 2022 Comes to a Close

by Ritujay Ghosh

Sandstorm Gold Ltd. (SAND), The Mosaic Company (MOS), The Ensign Group, Inc. (ENSG) and Preferred Bank (PFBC) recently hiked dividends.

Acadia Healthcare (ACHC) Up 42% in a Year: More Room to Run?

by Zacks Equity Research

Acadia Healthcare (ACHC) is well-poised for growth on a diversified healthcare treatment network resulting from growth-related efforts.

Ensign Group (ENSG) Unveils Dividend Hike to Reward Shareholders

by Zacks Equity Research

Ensign Group's (ENSG) latest dividend hike reflects strong financial standing and intensified focus in the tactical deployment of capital.

Ensign Group (ENSG) Facility Buyout to Boost Colorado Foothold

by Zacks Equity Research

Ensign Group (ENSG) acquires two skilled nursing facilities in Colorado that are likely to grow its healthcare portfolio and solidify its nationwide presence.

Ensign Group (ENSG) is a Top-Ranked Value Stock: Should You Buy?

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Zacks Equity Research

Sector ETF report for PSCH

Ensign Group (ENSG) Shares Up 2% Despite Q3 Earnings Miss

by Zacks Equity Research

Ensign Group's (ENSG) third-quarter results reflect strength in the Skilled Services segment. A hiked 2022 EPS guidance remains noteworthy. However, escalated expenses are bothersome.

Is Medpace (MEDP) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Medpace (MEDP) and Ensign Group (ENSG) have performed compared to their sector so far this year.

Ensign Group (ENSG) Q3 Earnings Lag Estimates

by Zacks Equity Research

Ensign Group (ENSG) delivered earnings and revenue surprises of -0.95% and 2.71%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Here's Why Ensign Group (ENSG) is a Strong Growth Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Acadia (ACHC) JV Breaks Ground for New Behavioral Health Unit

by Zacks Equity Research

Acadia Healthcare (ACHC) and Henry Ford Health expect the new hospital to start with 184 inpatient beds and later expand to 192 beds.

Why Should You Add Ensign Group (ENSG) to Portfolio Now?

by Zacks Equity Research

Ensign Group (ENSG) benefits from a growing healthcare portfolio as a result of multiple facility buyouts. Solid cash-generating abilities empower ENSG to invest in growth-related initiatives.

Humana (HUM) Brings Home Health Unit of KAH Under CenterWell

by Zacks Equity Research

Humana (HUM) wraps up rebranding KAH's home health operations to the CenterWell brand. This leads to the clubbing of HUM's three payer-agnostic care services into a common suite.

Ensign Group (ENSG) Down 2.9% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Cigna (CI) to Widen Access to Individual Health Plans in 2023

by Zacks Equity Research

Cigna (CI) unveils enhanced individual and family health plans for its customers to opt for in the 2023 Open Enrollment Period. CI will enter newer counties and states to offer better health outcomes.

Teladoc Health (TDOC) Ties Up to Upgrade RPM Care in Canada

by Zacks Equity Research

Teladoc Health (TDOC) teams up with Cloud DX to bring its virtual care capabilities to the latter's platform and dispense advanced RPM solutions to the Canadian residents.

Has BioCardia (BCDA) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Here is how BioCardia, Inc. (BCDA) and Ensign Group (ENSG) have performed compared to their sector so far this year.

Here's Why Ensign Group (ENSG) is a Strong Value Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Ensign Group (ENSG) Stock Up 6% Since Q2 Earnings Release

by Zacks Equity Research

Ensign Group's (ENSG) second-quarter results reflect revenue growth, and solid contributions from the Skilled Services and Standard Bearer segments. A hiked 2022 EPS guidance bodes well.

Here is Why Growth Investors Should Buy Ensign Group (ENSG) Now

by Zacks Equity Research

Ensign Group (ENSG) possesses solid growth attributes, which could help it handily outperform the market.

Ensign Group (ENSG) Meets Q2 Earnings Estimates

by Zacks Equity Research

Ensign Group (ENSG) delivered earnings and revenue surprises of 0% and 0.60%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?